Marion Saville

Surveillance systems for monitoring cervical cancer elimination efforts: Focus on HPV infection, cervical dysplasia, cervical screening and treatment

Julia ML Brotherton, Cosette Wheeler, Gary M Clifford, Miriam Elfstrom, Marion Saville, John Kaldor, Dorothy A Machalek

Journal article  |  2021  |  PREVENTIVE MEDICINE

In order to achieve the global elimination of cervical cancer as a public health problem, close surveillance of progress in public..

Could HPV Testing on Self-collected Samples Be Routinely Used in an Organized Cervical Screening Program? A Modeled Analysis

Megan A Smith, Michaela T Hall, Marion Saville, Julia ML Brotherton, Kate T Simms, Jie-Bin Lew, Deborah Bateson, S Rachel Skinner, Margaret Kelaher, Karen Canfell

Journal article  |  2021  |  CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

BACKGROUND: Cervical screening on self-collected samples has mainly been considered for targeted use in underscreened women. Updat..

HPV16/18 prevalence in high-grade cervical lesions in an Australian population offered catch-up HPV vaccination

Alyssa M Cornall, Marion Saville, Jan Pyman, Emma T Callegari, Fiona H Tan, Julia Ml Brotherton, Michael J Malloy, Sepehr N Tabrizi, C David Wrede, Suzanne M Garland

Journal article  |  2020  |  VACCINE

OBJECTIVES: Using laser capture microdissection (LCM) and sensitive human papillomavirus (HPV) genotyping, we aimed to determine t..

Assessment of attribution algorithms for resolving CIN3-related HPV genotype prevalence in mixed-genotype biopsy specimens using laser capture microdissection as the reference standard

Alyssa M Cornall, Julia ML Brotherton, Emma T Callegari, Fiona H Tan, Marion Saville, Jan Pyman, Samuel Phillips, Michael J Malloy, Sepehr N Tabrizi, Suzanne M Garland

Journal article  |  2020  |  VACCINE

To make accurate determinations regarding potential and actual impact of HPV vaccine programs, precise estimates of genotype-speci..

Evaluation of p16/Ki-67 dual-stain cytology performed on self-collected vaginal and clinician-collected cervical specimens for the detection of cervical pre-cancer

PJ Toliman, S Phillips, S de Jong, T O'Neill, G Tan, JML Brotherton, M Saville, JM Kaldor, AJ Vallely, SN Tabrizi

Journal article  |  2020  |  CLINICAL MICROBIOLOGY AND INFECTION

OBJECTIVES: To compare the performance of dual immunostaining of p16INK4a and Ki-67 proteins performed on self-collected vaginal s..

Self-Collection for Cervical Screening Programs: From Research to Reality

David Hawkes, Marco HT Keung, Yanping Huang, Tracey L McDermott, Joanne Romano, Marion Saville, Julia ML Brotherton

Journal article  |  2020  |  CANCERS

In 2018, there were an estimated 570,000 new cases of cervical cancer globally, with most of them occurring in women who either ha..

Monitoring human papillomavirus prevalence among young Australian women undergoing routine chlamydia screening

Hannah Shilling, Gerald Murray, Julia ML Brotherton, David Hawkes, Marion Saville, Terri Sivertsen, Ian Chambers, Jennifer Roberts, Annabelle Farnsworth, Suzanne M Garland, Jane S Hocking, John Kaldor, Rebecca Guy, Steph Atchison, Anna-Maria Costa, Monica Molano, Dorothy A Machalek

Journal article  |  2020  |  VACCINE

INTRODUCTION: Australia has recently implemented major changes in cervical cancer prevention policies including introduction of pr..

Implementation of Australia's renewed cervical screening program: Preparedness of general practitioners and nurses

Farhana Sultana, Lara Roeske, Michael J Malloy, Tracey L McDermott, Marion Saville, Julia ML Brotherton

Journal article  |  2020  |  PLOS ONE

The National Cervical Screening Program (NCSP) in Australia underwent major changes on December 1st, 2017. The program changed fro..

Compliance with follow-up Test of Cure and outcomes after treatment for high-grade cervical intraepithelial neoplasia in Victoria, Australia

Jeffrey HJ Tan, Michael J Malloy, Julia ML Brotherton, Marion Saville

Journal article  |  2020  |  AUSTRALIAN & NEW ZEALAND JOURNAL OF OBSTETRICS & GYNAECOLOGY

BACKGROUND: Test of Cure (ToC), a combination of testing for oncogenic human papillomavirus (HPV) and cytology, at 12 months post-..

Is one dose of human papillomavirus vaccine as effective as three?: A national cohort analysis

Julia ML Brotherton, Alison Budd, Christopher Rompotis, Natasha Bartlett, Michael J Malloy, Rachael L Andersen, Kim AR Coulter, Peter W Couvee, Nerida Steel, Gail H Ward, Marion Saville

Journal article  |  2019  |  PAPILLOMAVIRUS RESEARCH

AIM: Prophylactic human papillomavirus (HPV) vaccines are highly effective at preventing pre-cancerous cervical lesions when given..